Fleming Fund Country Grant: Papua New Guinea
Burnet Institute is leading the implementation of the Papua New Guinea (PNG) Country Grant component of the Fleming Fund, a £500 million UK Aid program helping to tackle antimicrobial resistance (AMR) in low- and middle-income countries.
Objective
Background
AMR is an issue of global concern: if current trends continue, health economists estimate that worldwide by 2050 AMR could result in up to 10 million deaths each year and USD100 trillion lost in economic activity.
As drug resistant bacteria can spread freely around the environment, responses to AMR must involve multiple sectors.Our project brings together a unique collaboration of experts in animal and human health, microbiology and surveillance, information technology and construction, all to support PNG’s domestic responses to address AMR.
Our PNG project aims to:
- strengthen One Health approaches to information sharing
- strengthen antimicrobial resistance (AMR), antimicrobial use (AMU) and antimicrobial consumption (AMC) surveillance and monitoring systems in the human health sector
- strengthen antimicrobial resistance (AMR) and antimicrobial use (AMU) surveillance and monitoring systems in the animal health sector.
Timeline
2020–2025.
Approach
Our project’s key activities included:
- strengthening national and subnational AMR governance structures including the establishment of active working groups across key sectors in PNG
- workforce development such as training laboratory personnel in biosafety and laboratory management
- enhancing animal health and human health laboratory infrastructure to support surveillance and diagnostic capabilities for AMR.
The Fleming Fund PNG project is establishing bacteriology diagnostics in laboratories throughout the country benefiting patients admitted to provincial hospitals in the Western Highlands, Eastern Highlands, Morobe and East New Britain provinces, as well as the National Capital District.
This laboratory strengthening has already assisted PNG with their COVID-19 responses.
The project embraces a One Health approach. The combination of human and animal AMR surveillance will allow PNG to better understand the extent of AMR across the country and develop strategies to address AMR.
Partners
Funding partners
Fleming Fund (through UK Aid Department of Health and Social Services), managed by Mott MacDonald.
Phase One: A$14 million.
Phase Two: A$6.35 million.
Collaborators
- PNG Government and PNG Institute of Medical Research
- Beyond EssenDal Systems (BES)
- Asia Pacific Centre for Animal Health
- Conrad Gargett Architects
Project contacts

Professor Robert Power AM
Fleming Fund Program Director; Project Consultant
Project team

Possawat Jorakate
Technical Coordinator

Mona Kheng
Surveillance Officer – Antimicrobial Resistance

James Lawson
Program Manager / Country Program Manager

Dr Nomvuyo Mothobi
Technical Advisor

Professor Robert Power AM
Fleming Fund Program Director; Project Consultant

Dr Amrita Ronnachit
Senior Technical Advisor
